Skip to main content
. 2021 Jan 24;106(4):484–492. doi: 10.1111/ejh.13572

FIGURE 2.

FIGURE 2

Comparison of prevalence estimates of select comorbidities and complications limited to an average of 8 y prior to enrollment in PK deficiency NHS or index date in MarketScan. *P < .001 for PK deficiency NHS population vs matched general population. NHS, Natural History Study; PK, pyruvate kinase